BioPharma Dive: Marketing | July 18 | AbbVie delays another Humira rival | PhRMA proposes rebate shake-up

Top Marketing News

Weekly edition | July​ 18,​ 2018


HEADLINES:

BROUGHT TO YOU BY — BioPharma Dive Brand Studio

  • How molecular biomarkers are transforming cancer treatment
  • AbbVie goes 3-0 in delaying Humira rivals
  • Drug lobby aims to shake up how medicines are paid for
  • Where does J&J’s new drug fit in the crowded HIV market?
  • 5 drugs to watch as biotechs report Q2
  • FDA seeks to make more drugs available over the counter
  • Gilenya patent decision gives MS market a reprieve

PLUS >>> What they are reading:

BLOOMBERG

  • Trump Fails at Lowering Drug Prices as Costs Keep Going Up

STAT

  • In prescription drug business, will Amazon partner with PBMs, or seek to conquer them?

FIERCE PHARMA

  • Vertex says it’s glad England made another offer for CF drugs, but it’ll have to do better

MM&M

  • Publicis Health acquires Payer Sciences

 


Read all the above via the following link >>>

BioPharma Dive: Marketing ~July 18


About BioPharma Dive
Our mission is to provide busy execs like you with an overview of the BioPharma industry in 60 seconds. BioPharma Dive is a product of Industry Dive.
View other Industry Dive publications.

Please remember that we subscribe to receive this newsletter.

Please remember to check out the privacy policies and disclaimers, here, and there!

Many thanks ~ Carole

thermometer on medical pills
Photo by Pixabay on Pexels.com
Advertisements